Cleveland BioLabs, Inc. (NASDAQ: CBLI) has been awarded a $5.3 million Grand Opportunities grant under the American Recovery and ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE